RxDoctor Payments Data

Michael Caskey

Phoenix, AZNPI 1326032111

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,215,373 of the $4,897,332 with a category attached, or 86.1%. Medtronic accounts for 100.0% of it on its own, with 3 other manufacturers making up the rest.

$4,897,332in general payments, 2019–2025

Across 2,310 payments — averaging $2120.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4.9M
  • Abbott$435
  • Edwards Lifesciences$431
  • Elutia, Inc.$15
$57,466in research payments, 2019–2025

Across 64 payments — averaging $897.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$57K

What the payments were for

  • Consulting fees$39,2381%
  • Speaking & faculty fees$4,215,37386%
  • Grants$1230%
  • Travel & lodging$597,69312%
  • Food & beverage$44,0581%
  • Education$8480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)2,295$4,896,451
Abbott3$435
Edwards Lifesciences11$431
Elutia, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →